HERBORIUM GROUP Business Summary

Herborium Group Inc. (HBRM) is a specialized botanical therapeutics company that develops, licenses, and markets proprietary, plant-based medicinal products designed to bridge the gap between traditional herbal remedies and synthetic pharmaceuticals. The company generates revenue primarily through direct-to-consumer (DTC) e-commerce sales, international distributors, and specialty retailers. Its business is organized into three primary segments: Dermatology, anchored by its flagship clinically-validated acne and Rosacea treatment AcnEase; Sexual Health, featuring non-prescription performance enhancers; and Energy/Wellness, which includes the Lasting Energy supplement line. Within the competitive landscape, Herborium contends with major skincare and supplement players such as Murad, Galderma, Proactiv, and Gaia Herbs. The company distinguishes itself through a "Botanical Therapeutics" positioning, leveraging clinical validation to offer premium, natural alternatives to traditional over-the-counter and prescription treatments for chronic conditions. The company was co-founded by Dr. Agnes P. Olszewski and Dr. James P. Gilligan, who continue to lead the organization as of 2026. Dr. Olszewski serves as the Chief Executive Officer, Chief Financial Officer, and Chairwoman, bringing over 20 years of experience in global marketing and business strategy. Dr. Gilligan, acting as a Director and Scientific Advisor, contributes over 25 years of expertise in biotechnology and drug development. The leadership team is further bolstered by Senior Vice President of Business Development Daniel Teo and Asia Business Advisor Lawrence Woo, the former President of Pfizer Greater China. Notable board members include Sir Roger Jones, a veteran of the UK pharmaceutical industry. In 2024, the company secured a strategic funding agreement with Stardust Holdings LLC to support the expansion of its AI-driven "Content Plus Product" platform, SKINTELL, aimed at personalizing natural self-care regimens.